REAL-WORLD EXPERIENCE OF GLECAPREVIR/PIBRENTASVIR TREATMENT IN JAPANESE ADOLESCENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

被引：0

作者：

Mizuochi, Tatsuki ^{[1
]}

Iwama, Itaru ^{[2
]}

Inui, Ayano ^{[3
]}

Ito, Yoshinori ^{[4
]}

Takaki, Yugo ^{[5
]}

Mushiake, Sotaro ^{[6
]}

Tokuhara, Daisuke ^{[7
]}

Ishige, Takashi ^{[8
]}

Ito, Koichi ^{[9
]}

Murakami, Jun ^{[10
]}

Hishiki, Haruka ^{[11
]}

Mikami, Hitoshi ^{[12
]}

Bessho, Kazuhiko ^{[13
]}

Kato, Ken ^{[1
]}

Yasuda, Ryosuke ^{[1
]}

Yamashita, Yushiro ^{[1
]}

Tanaka, Yasuhito ^{[14
,15
,16
]}

Tajiri, Hitoshi ^{[17
]}

机构：

[1] Kurume Univ, Pediat & Child Hlth, Sch Med, Kurume, Fukuoka, Japan

[2] Saitama Childrens Med Ctr, Gastroenterol & Hepatol, Saitama, Japan

[3] Saiseikai Yokohamashi Tobu Hosp, Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan

[4] Nagoya Univ, Pediat, Grad Sch Med, Nagoya, Aichi, Japan

[5] Japanese Red Cross Kumamoto Hosp, Pediat, Kumamoto, Japan

[6] Kindai Univ, Pediat, Nara Hosp, Higashiosaka, Osaka, Japan

[7] Osaka City Univ, Pediat, Grad Sch Med, Osaka, Japan

[8] Gunma Univ, Pediat, Grad Sch Med, Gunma, Japan

[9] Nagoya City Univ, Grad Sch Med Sci, Pediat & Neonatol, Nagoya, Aichi, Japan

[10] Tottori Univ, Pediat & Perinatol, Fac Med, Tottori, Japan

[11] Chiba Univ Hosp, Pediat, Chiba, Japan

[12] Iwate Prefectural Cent Hosp, Pediat, Morioka, Iwate, Japan

[13] Osaka Univ, Grad Sch Med, Pediat, Osaka, Japan

[14] Kumamoto Univ, Dept Gastroenterol & Hepatol, Fac Life Sci, Kumamoto, Japan

[15] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[16] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan

[17] Kindai Univ, Pediat, Fac Med, Higashihiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4803

引用

页码：S1524 / S1525

页数：2

共 50 条

[21] Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
Toyoda, Hidenori
Atsukawa, Masanori
Watanabe, Tsunamasa
Nakamuta, Makoto
Uojima, Haruki
Nozaki, Akito
Takaguchi, Koichi
Fujioka, Shinichi
Iio, Etsuko
Shima, Toshihide
Akahane, Takehiro
Fukunishi, Shinya
Asano, Toru
Michitaka, Kojiro
Tsuji, Kunihiko
Abe, Hiroshi
Mikami, Shigeru
Okubo, Hironao
Okubo, Tomomi
Shimada, Noritomo
Ishikawa, Toru
Moriya, Akio
Tani, Joji
Morishita, Asahiro
Ogawa, Chikara
Tachi, Yoshihiko
Ikeda, Hiroki
Yamashita, Naoki
Yasuda, Satoshi
Chuma, Makoto
Tsutsui, Akemi
Hiraoka, Atsushi
Ikegami, Tadashi
Genda, Takuya
Tsubota, Akihito
Masaki, Tsutomu
Tanaka, Yasuhito
Iwakiri, Katsuhiko
Kumada, Takashi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (05) : 855 - 861
[22] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Akito Nozaki
Masanori Atsukawa
Chisa Kondo
Hidenori Toyoda
Makoto Chuma
Makoto Nakamuta
Haruki Uojima
Koichi Takaguchi
Hiroki Ikeda
Tsunamasa Watanabe
Shintaro Ogawa
Norio Itokawa
Taeang Arai
Atsushi Hiraoka
Toru Asano
Shinichi Fujioka
Tadashi Ikegami
Toshihide Shima
Chikara Ogawa
Takehiro Akahane
Noritomo Shimada
Shinya Fukunishi
Hiroshi Abe
Akihito Tsubota
Takuya Genda
Hironao Okubo
Shigeru Mikami
Asahiro Morishita
Akio Moriya
Joji Tani
Yoshihiko Tachi
Naoki Hotta
Toru Ishikawa
Takeshi Okanoue
Yasuhito Tanaka
Takashi Kumada
Katsuhiko Iwakiri
Shin Maeda
Hepatology International, 2020, 14 : 225 - 238
[23] REAL-WORLD EXPERIENCE OF 12-WEEK DAA REGIMEN OF GLECAPREVIR AND PIBRENTASVIR IN JAPANESE PATIENTS WITH CHRONIC HCV INFECTION
Yasuda, Satoshi
Toyoda, Hidenori
Iio, Etsuko
Akahane, Takehiro
Fujioka, Shinichi
Kunihiko, Tsuji
Shimada, Noritomo
Ishikawa, Toru
Tachi, Yoshihiko
Hotta, Naoki
Tanaka, Yasuhito
Kumada, Takashi
HEPATOLOGY, 2019, 70 : 928A - 928A
[24] Real-World Data on the Use of Glecaprevir/Pibrentasvir in the Treatment of Hepatitis C: Is Shorter Treatment Possible?
Tuzun, Ahmet Yekta
Mermutluoglu, Cigdem
Celen, Mustafa Kemal
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2024, 30 (02): : 36 - 40
[25] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Nozaki, Akito
Atsukawa, Masanori
Kondo, Chisa
Toyoda, Hidenori
Chuma, Makoto
Nakamuta, Makoto
Uojima, Haruki
Takaguchi, Koichi
Ikeda, Hiroki
Watanabe, Tsunamasa
Ogawa, Shintaro
Itokawa, Norio
Arai, Taeang
Hiraoka, Atsushi
Asano, Toru
Fujioka, Shinichi
Ikegami, Tadashi
Shima, Toshihide
Ogawa, Chikara
Akahane, Takehiro
Shimada, Noritomo
Fukunishi, Shinya
Abe, Hiroshi
Tsubota, Akihito
Genda, Takuya
Okubo, Hironao
Mikami, Shigeru
Morishita, Asahiro
Moriya, Akio
Tani, Joji
Tachi, Yoshihiko
Hotta, Naoki
Ishikawa, Toru
Okanoue, Takeshi
Tanaka, Yasuhito
Kumada, Takashi
Iwakiri, Katsuhiko
Maeda, Shin
HEPATOLOGY INTERNATIONAL, 2020, 14 (02) : 225 - 238
[26] Real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: updated data from the German Hepatitis C-Registry
Cornberg, M.
Naumann, U.
Stoehr, A.
Sick, C.
Teuber, G.
Schiffelholz, W.
Mauss, S.
Lohmann, K.
Kleine, H.
Pangerl, A.
Mueller, T.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 197 - 198
[27] First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry
Berg, T.
Naumann, U.
Stoehr, A.
Sick, C.
Teuber, G.
Schiffelholz, W.
Mauss, S.
Hettinger, J.
Kleine, H.
Pangerl, A.
Niederau, C.
JOURNAL OF HEPATOLOGY, 2018, 68 : S37 - S37
[28] Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases
Sugiura, Ayumi
Joshita, Satoru
Yamashita, Yuki
Yamazaki, Tomoo
Fujimori, Naoyuki
Kimura, Takefumi
Matsumoto, Akihiro
Wada, Shuichi
Mori, Hiromitsu
Shibata, Soichiro
Yoshizawa, Kaname
Morita, Susumu
Furuta, Kiyoshi
Kamijo, Atsushi
Iijima, Akihiro
Kako, Satoko
Maruyama, Atsushi
Kobayashi, Masakazu
Komatsu, Michiharu
Matsumura, Makiko
Miyabayashi, Chiharu
Ichijo, Tetsuya
Takeuchi, Aki
Koike, Yuriko
Gibo, Yukio
Tsukadaira, Toshihisa
Inada, Hiroyuki
Nakano, Yoshiyuki
Usuda, Seiichi
Kiyosawa, Kendo
Tanaka, Eiji
Umemura, Takeji
BIOMEDICINES, 2020, 8 (04)
[29] Prospective multicenter study of glecaprevir plus pibrentasvir combination therapy for patients with chronic hepatitis C
Tamori, Akihiro
Iwasa, Motoo
Inoue, Kazuaki
Kagawa, Tatehiro
Takaguchi, Koichi
Minami, Masahito
Iwasaki, Yoshiaki
Nouso, Kazuhiro
Hoang, Hai
Enomoto, Masaru
Kawada, Norifumi
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E242 - E243
[30] Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter Study
Stinco, Mariangela
Rubino, Chiara
Bartolini, Elisa
Nuti, Federica
Paolella, Giulia
Nebbia, Gabriella
Silvestro, Erika
Garazzino, Silvia
Nicastro, Emanuele
D'Antiga, Lorenzo
Zanchi, Chiara
Morra, Laura
Iorio, Raffaele
Di Dato, Fabiola
Maggiore, Giuseppe
Sartorelli, Maria Rita
Comparcola, Donatella
Stracuzzi, Marta
Giacomet, Vania
Musto, Francesca
Pinon, Michele
Calvo, Pierluigi
Carloni, Ines
Zallocco, Federica
Cananzi, Mara
Trapani, Sandra
Indolfi, Giuseppe
LIVER INTERNATIONAL, 2025, 45 (04)

← 1 2 3 4 5 →